title: Endometrial adenocarcinoma: a primer for the generalist.
abstract: Endometrial cancer is the most common gynecologic malignancy in the United States. The mean and median age of women with endometrial adenocarcinoma is 61 years. Most endometrial cancers are type I estrogen-dependent endometrioid adenocarcinomas. Most women with endometrial adenocarcinoma have stage I disease. Patients with stage I disease endometrial adenocarcinoma can be treated with a simple hysterectomy, bilateral salpingo-oophorectomy, peritoneal lavage, and periaortic node dissection in selected cases. The probability of survival according to international statistics is as follows: stage IA, 91%; stage IB, 88%; stage IC, 81%; stage IIA, 77%; stage IIB, 67%; stage IIA, 60%; stage IIIB, 41%; stage IIC, 32%; stage IVA, 20%; stage IVB, 5%.
authors.affiliation: Division of Gynecologic Oncology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA. ehernand@unix.temple.edu
authors.forename: E
authors.initials: E
authors.lastname: Hernandez
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000628:therapy*; D001706:Biopsy / Q000379:methods; D016889:Endometrial Neoplasms / Q000175:diagnosis / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D010533:Peritoneal Lavage / Q000379:methods; D012307:Risk Factors; D015996:Survival Rate